Illumina ILMN Stock
Illumina Price Chart
Illumina ILMN Financial and Trading Overview
| Illumina stock price | 129.64 USD |
| Previous Close | 97.93 USD |
| Open | 98.96 USD |
| Bid | 91.25 USD x 100 |
| Ask | 102 USD x 100 |
| Day's Range | 95.54 - 99.34 USD |
| 52 Week Range | 68.7 - 156.66 USD |
| Volume | 1.89M USD |
| Avg. Volume | 2.19M USD |
| Market Cap | 15.22B USD |
| Beta (5Y Monthly) | 1.326 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 4.46 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 109.01 USD |
ILMN Valuation Measures
| Enterprise Value | 16.47B USD |
| Trailing P/E | N/A |
| Forward P/E | 21.751131 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.5090988 |
| Price/Book (mrq) | 6.455382 |
| Enterprise Value/Revenue | 3.798 |
| Enterprise Value/EBITDA | 17.196 |
Trading Information
Illumina Stock Price History
| Beta (5Y Monthly) | 1.326 |
| 52-Week Change | -18.25% |
| S&P500 52-Week Change | 13.16% |
| 52 Week High | 156.66 USD |
| 52 Week Low | 68.7 USD |
| 50-Day Moving Average | 88.46 USD |
| 200-Day Moving Average | 110.25 USD |
ILMN Share Statistics
| Avg. Volume (3 month) | 2.19M USD |
| Avg. Daily Volume (10-Days) | 2.21M USD |
| Shares Outstanding | 158.3M |
| Float | 153.95M |
| Short Ratio | 2.86 |
| % Held by Insiders | 0.19% |
| % Held by Institutions | 106.75% |
| Shares Short | 6.3M |
| Short % of Float | 6.09% |
| Short % of Shares Outstanding | 3.98% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1028:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 29, 2024 |
| Most Recent Quarter (mrq) | March 30, 2025 |
| Next Fiscal Year End | December 29, 2025 |
Profitability
| Profit Margin | -22.27% |
| Operating Margin (ttm) | 17.67% |
| Gross Margin | 68.61% |
| EBITDA Margin | 22.08% |
Management Effectiveness
| Return on Assets (ttm) | 4.95% |
| Return on Equity (ttm) | -23.84% |
Income Statement
| Revenue (ttm) | 4.34B USD |
| Revenue Per Share (ttm) | 27.28 USD |
| Quarterly Revenue Growth (yoy) | -3.30% |
| Gross Profit (ttm) | 2.98B USD |
| EBITDA | 958M USD |
| Net Income Avi to Common (ttm) | -966000000 USD |
| Diluted EPS (ttm) | -6.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.24B USD |
| Total Cash Per Share (mrq) | 7.81 USD |
| Total Debt (mrq) | 2.61B USD |
| Total Debt/Equity (mrq) | 110.09 USD |
| Current Ratio (mrq) | 1.856 |
| Book Value Per Share (mrq) | 14.893 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1B USD |
| Levered Free Cash Flow (ttm) | 381M USD |
Profile of Illumina
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 5200 Illumina Way |
| ZIP | 92122 |
| Phone | 858 202 4500 |
| Website | https://www.illumina.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 8970 |
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Q&A For Illumina Stock
What is a current ILMN stock price?
Illumina ILMN stock price today per share is 129.64 USD.
How to purchase Illumina stock?
You can buy ILMN shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Illumina?
The stock symbol or ticker of Illumina is ILMN.
Which industry does the Illumina company belong to?
The Illumina industry is Diagnostics & Research.
How many shares does Illumina have in circulation?
The max supply of Illumina shares is 153.7M.
What is Illumina Price to Earnings Ratio (PE Ratio)?
Illumina PE Ratio is 29.06726500 now.
What was Illumina earnings per share over the trailing 12 months (TTM)?
Illumina EPS is 4.46 USD over the trailing 12 months.
Which sector does the Illumina company belong to?
The Illumina sector is Healthcare.
Illumina ILMN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23025.59 USD — |
+0.67
|
7.45B USD — | 22587.11 USD — | 23070.09 USD — | — - | 7.45B USD — |
| S&P 500 INDEX SPX | 6765.88 USD — |
+0.91
|
3.32B USD — | 6659.98 USD — | 6776.4 USD — | — - | 3.32B USD — |
| S&P 500 (Yahoo.com) GSPC | 6765.88 USD — |
+0.91
|
3.3B USD — | 6659.98 USD — | 6776.4 USD — | — - | 3.3B USD — |
| US100 NDX | 25018.36 USD — |
+0.58
|
1.41B USD — | 24542.72 USD — | 25069.54 USD — | — - | 1.41B USD — |
| Dow Jones U.S. Biotechnology In DJUSBT | 3244.94 USD — |
+1.6
|
103.12M USD — | 3196.08 USD — | 3252.19 USD — | — - | 103.12M USD — |
| US Tech CRD Global Sustainabilit NQCRD | 1735.62 USD — |
0
|
— — | 1715.94 USD — | 1757.95 USD — | — - | — — |
| US Tech-100 Ex-Tech Sector NDXX | 5885.86 USD — |
+1.18
|
— — | 5823.82 USD — | 5891.35 USD — | — - | — — |
| US Tech-100 Total Return XNDX | 30409.47 USD — |
+0.58
|
— — | 29831.33 USD — | 30471.68 USD — | — - | — — |
| US Tech-100 ESG JPY Index NDXESG07 | 2619.44 JPY 17.68 USD |
-0.07
|
— — | 2564.13 JPY 17.31 USD | 2625.24 JPY 17.72 USD | — - | — — |
| US Tech Biotechnology Total Retu XNBI | 6266.78 USD — |
+1.37
|
— — | 6197.52 USD — | 6268.3 USD — | — - | — — |
| Stlmt ID US Tech 100 XQO | 16266.86 USD — |
-0.45
|
— — | 15738.2 USD — | 16639.8 USD — | — - | — — |
| US Tech-100 Notional Net Return XNDXNNREUR | 4513.63 EUR 4934.01 USD |
+0.29
|
— — | 4424.01 EUR 4836.04 USD | 4523.91 EUR 4945.24 USD | — - | — — |
| US Tech Biotechnology NBI | 5763.13 USD — |
+1.37
|
— — | 5699.44 USD — | 5764.53 USD — | — - | — — |
| US Tech-100 After Hours Indicato QIV | 25008.98 USD — |
+0.54
|
— — | 24987.53 USD — | 25024.81 USD — | — - | — — |
| US Tech Health Care IXHC | 1204.14 USD — |
+1.48
|
— — | 1188.53 USD — | 1204.68 USD — | — - | — — |
| US Tech-100 Reduced Value Index NQX | 5003.67 USD — |
+0.58
|
— — | 4908.56 USD — | 5013.91 USD — | — - | — — |
| US Tech Global Select Market Com NQGS | 11288.81 USD — |
+0.65
|
— — | 11074.26 USD — | 11311.27 USD — | — - | — — |
| US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| US Tech-100 Equal Weighted Total NETR | 10190.09 USD — |
+1.01
|
— — | 10031.12 USD — | 10204.48 USD — | — - | — — |
| US Tech-100 ESG Net Notional Tot NDXESG24 | 1942.16 EUR 2123.04 USD |
+0.05
|
— — | 1902.46 EUR 2079.65 USD | 1946.75 EUR 2128.06 USD | — - | — — |
- {{ link.label }} {{link}}